Chronic Pain News and Research

RSS

Black patients with chronic pain less likely to have obesity measured

At the intersection of two U.S. health epidemics - obesity and chronic pain - researchers from the University of Michigan Health System found black patients with chronic pain were less likely to have their weight or body mass index (BMI) recorded, even though they are at higher risk for having obesity when compared with their white counterparts.

14 Oct 2008

Dollar-sized medical device provides injured military skydiver with pain relief

St. Jude Medical, Inc. today announced the first patient implant of an Eon Mini, the world's smallest, longest-lasting, rechargeable neurostimulator to treat chronic pain of the trunk or limbs and pain from failed back surgery.

17 Sep 2008

Carbon nanotube coating improves electrical stimulation therapy used for Parkinson's, depression, chronic pain

Researchers at UT Southwestern Medical Center have designed a way to improve electrical stimulation of nerves by outfitting electrodes with the latest in chemically engineered fashion: a coating of basic black, formed from carbon nanotubes.

16 Sep 2008

New cannabis-like drugs could block pain without affecting brain

A new type of drug could alleviate pain in a similar way to cannabis without affecting the brain, according to a new study published in the journal Pain on Monday 15 September.

15 Sep 2008

NIH tackles urologic chronic pelvic pain disorders

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), announces awards to eight academic research centers to conduct collaborative studies of urologic chronic pelvic pain disorders by looking for clues outside the bladder and prostate. The total research investment for the five-year project is estimated to be up to $37.5 million.

7 Sep 2008

Over 10 million Americans are taking opioids

Researchers from Boston University's Slone Epidemiology Center have found that in a given week, over 10 million Americans are taking opioids, and more than 4 million are taking them regularly (at least five days per week, for at least four weeks). These findings appear in the August 31 issue of the journal Pain.

27 Aug 2008

BioAlliance Pharma granted patent on Lauriad technology in Europe

The patent describes and protects a muco-adhesive tablet for various applications in the field of opportunistic infections associated with AIDS and cancer. It has been validated in the main European countries and the opposition period has now expired.

24 Aug 2008

St. Jude Medical receives approval of first extended-life primary cell neurostimulator for treatment of chronic pain

St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approvals of EonC, the first extended-life primary cell (non-rechargeable) neurostimulator for the treatment of chronic pain.

13 Aug 2008

IMPAX sued for patent infringement on generic Ultram ER

IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. ("Purdue"), Napp Pharmaceutical Group Ltd. ("Napp"), Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application ("ANDA") for tramadol hydrochloride extended-release tablets (100 mg), generic of Ultram ER, to the Food and Drug Administration.

12 Aug 2008

Chronic pain among women may be down to low levels of vitamin D

According to new research published ahead of print, low vitamin D levels may contribute to chronic pain in women.

12 Aug 2008

Watson Pharmaceuticals announces limited recall of Fentanyl transdermal patches

Watson Pharmaceuticals, Inc. has announced that one lot of 75 mcg/hr Fentanyl Transdermal System patches sold in the United States is being voluntarily recalled from wholesalers and pharmacies.

10 Aug 2008

600,000 Australians afflicted with osteoporosis

According to a new report by the Australian Institute of Health and Welfare (AIHW) and Osteoporosis Australia, more than 600,000 Australians are affected by osteoporosis.

5 Aug 2008

Epilepsy drug gabapentin may reduce insomnia in recovering alcoholics

It's a Catch-22 of the highest order. People with alcohol problems often use alcohol to get to sleep -- but it actually keeps them from getting good-quality sleep all night long.

4 Aug 2008

Susceptibility to pain is affected by premature birth and also genetics

Scientists in US and UK laboratories have made key discoveries into the elusive nature of pain in children and adults. The results, presented at the Forum of European Neurosciences Monday will help guide the future management and treatment of pain.

14 Jul 2008

Oregano helps against Inflammations

Oregano doesn't only give a Pizza its typical taste. Researchers at Bonn University and the ETH Zurich have discovered that this spice also contains a substance which, amongst other qualities, appears to help cure inflammations.

25 Jun 2008

Pitt awarded $2.5 million to model how the brain and immune system function in response to illness, infection

In an effort to promote the application of mathematics to medical treatment, researchers in the University of Pittsburgh's Department of Mathematics will undertake a $2.5 million project to create models of how the brain and immune system function and change over time in response to certain illnesses, infections, and treatment.

24 Jun 2008

Oral cannabis ineffective in treating acute pain

A study published in the July issue of the Journal Anesthesiology discovered that oral cannabis (a form of medical marijuana) not only failed to alleviate certain types of pain in human volunteers but, surprisingly, it instead caused increased sensitivity to some forms of pain.

24 Jun 2008

Reverse shoulder surgery

When Gary Meyewski fell and shattered his humerus in three places in 2006, his quality of life was shattered as well. With the ball and socket in his shoulder severely damaged, he lost all function in his shoulder, experiencing a drastic loss of mobility, and eventually severe, chronic pain.

23 Jun 2008

Medicines derived from cannabis: A review of adverse events

Researchers at the McGill University Health Centre (MUHC), McGill University and the University of British Columbia (UBC) determined that medical use of cannabinoids do not cause an increase in serious adverse events, but are associated with an increase in some non-serious adverse events.

16 Jun 2008

Cymbalta approved for fibromyalgia

The U.S. Food and Drug Administration (FDA) has approved Cymbalta (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company announced.

16 Jun 2008